BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 21946537)

  • 1. Somatic deletions of genes regulating MSH2 protein stability cause DNA mismatch repair deficiency and drug resistance in human leukemia cells.
    Diouf B; Cheng Q; Krynetskaia NF; Yang W; Cheok M; Pei D; Fan Y; Cheng C; Krynetskiy EY; Geng H; Chen S; Thierfelder WE; Mullighan CG; Downing JR; Hsieh P; Pui CH; Relling MV; Evans WE
    Nat Med; 2011 Sep; 17(10):1298-303. PubMed ID: 21946537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteasome inhibition rescues clinically significant unstable variants of the mismatch repair protein Msh2.
    Arlow T; Scott K; Wagenseller A; Gammie A
    Proc Natl Acad Sci U S A; 2013 Jan; 110(1):246-51. PubMed ID: 23248292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OTUB1 stabilizes mismatch repair protein MSH2 by blocking ubiquitination.
    Wu Q; Huang Y; Gu L; Chang Z; Li GM
    J Biol Chem; 2021; 296():100466. PubMed ID: 33640455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elucidating the molecular basis of MSH2-deficient tumors by combined germline and somatic analysis.
    Vargas-Parra GM; González-Acosta M; Thompson BA; Gómez C; Fernández A; Dámaso E; Pons T; Morak M; Del Valle J; Iglesias S; Velasco À; Solanes A; Sanjuan X; Padilla N; de la Cruz X; Valencia A; Holinski-Feder E; Brunet J; Feliubadaló L; Lázaro C; Navarro M; Pineda M; Capellá G
    Int J Cancer; 2017 Oct; 141(7):1365-1380. PubMed ID: 28577310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EPCAM germline and somatic rearrangements in Lynch syndrome: identification of a novel 3'EPCAM deletion.
    Spaepen M; Neven E; Sagaert X; De Hertogh G; Beert E; Wimmer K; Matthijs G; Legius E; Brems H
    Genes Chromosomes Cancer; 2013 Sep; 52(9):845-54. PubMed ID: 23801599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional analysis of HNPCC-related missense mutations in MSH2.
    Lützen A; de Wind N; Georgijevic D; Nielsen FC; Rasmussen LJ
    Mutat Res; 2008 Oct; 645(1-2):44-55. PubMed ID: 18822302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and genomic basis of the mismatch repair system involved in Lynch syndrome.
    Tamura K; Kaneda M; Futagawa M; Takeshita M; Kim S; Nakama M; Kawashita N; Tatsumi-Miyajima J
    Int J Clin Oncol; 2019 Sep; 24(9):999-1011. PubMed ID: 31273487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone deacetylase 10 regulates DNA mismatch repair and may involve the deacetylation of MutS homolog 2.
    Radhakrishnan R; Li Y; Xiang S; Yuan F; Yuan Z; Telles E; Fang J; Coppola D; Shibata D; Lane WS; Zhang Y; Zhang X; Seto E
    J Biol Chem; 2015 Sep; 290(37):22795-804. PubMed ID: 26221039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Saccharomyces cerevisiae Msh2-Msh6 DNA binding kinetics reveal a mechanism of targeting sites for DNA mismatch repair.
    Zhai J; Hingorani MM
    Proc Natl Acad Sci U S A; 2010 Jan; 107(2):680-5. PubMed ID: 20080735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of DNA mismatch repair proteins in acute lymphoblastic leukaemia and normal bone marrow.
    Matheson EC; Hall AG
    Adv Exp Med Biol; 1999; 457():579-83. PubMed ID: 10500837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minor Changes in Expression of the Mismatch Repair Protein MSH2 Exert a Major Impact on Glioblastoma Response to Temozolomide.
    McFaline-Figueroa JL; Braun CJ; Stanciu M; Nagel ZD; Mazzucato P; Sangaraju D; Cerniauskas E; Barford K; Vargas A; Chen Y; Tretyakova N; Lees JA; Hemann MT; White FM; Samson LD
    Cancer Res; 2015 Aug; 75(15):3127-38. PubMed ID: 26025730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective radiosensitization of drug-resistant MutS homologue-2 (MSH2) mismatch repair-deficient cells by halogenated thymidine (dThd) analogues: Msh2 mediates dThd analogue DNA levels and the differential cytotoxicity and cell cycle effects of the dThd analogues and 6-thioguanine.
    Berry SE; Davis TW; Schupp JE; Hwang HS; de Wind N; Kinsella TJ
    Cancer Res; 2000 Oct; 60(20):5773-80. PubMed ID: 11059773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of MLH1 and MSH2 DNA mismatch repair proteins in cell lines of the NCI anticancer drug screen.
    Taverna P; Liu L; Hanson AJ; Monks A; Gerson SL
    Cancer Chemother Pharmacol; 2000; 46(6):507-16. PubMed ID: 11138465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemistry for PMS2 and MSH6 alone can replace a four antibody panel for mismatch repair deficiency screening in colorectal adenocarcinoma.
    Hall G; Clarkson A; Shi A; Langford E; Leung H; Eckstein RP; Gill AJ
    Pathology; 2010; 42(5):409-13. PubMed ID: 20632815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microsatellite instability and p53 mutations are associated with abnormal expression of the MSH2 gene in adult acute leukemia.
    Zhu YM; Das-Gupta EP; Russell NH
    Blood; 1999 Jul; 94(2):733-40. PubMed ID: 10397740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of the spectrum of genomic deletions in the mismatch repair genes MSH2, MLH1, MSH6, and PMS2 responsible for hereditary nonpolyposis colorectal cancer (HNPCC).
    van der Klift H; Wijnen J; Wagner A; Verkuilen P; Tops C; Otway R; Kohonen-Corish M; Vasen H; Oliani C; Barana D; Moller P; Delozier-Blanchet C; Hutter P; Foulkes W; Lynch H; Burn J; Möslein G; Fodde R
    Genes Chromosomes Cancer; 2005 Oct; 44(2):123-38. PubMed ID: 15942939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compromised repair of clustered DNA damage in the human acute lymphoblastic leukemia MSH2-deficient NALM-6 cells.
    Holt SM; Scemama JL; Panayiotidis MI; Georgakilas AG
    Mutat Res; 2009 Mar; 674(1-2):123-30. PubMed ID: 18955159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA mismatch repair proteins are required for efficient herpes simplex virus 1 replication.
    Mohni KN; Mastrocola AS; Bai P; Weller SK; Heinen CD
    J Virol; 2011 Dec; 85(23):12241-53. PubMed ID: 21957315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mismatch repair and the downstream target genes, PAX5 and Ikaros, in childhood acute lymphoblastic leukemia.
    Best A; Matheson E; Minto L; Hall AG; Irving JA
    Leuk Res; 2010 Aug; 34(8):1098-102. PubMed ID: 20233627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ubiquitin-specific Peptidase 10 (USP10) Deubiquitinates and Stabilizes MutS Homolog 2 (MSH2) to Regulate Cellular Sensitivity to DNA Damage.
    Zhang M; Hu C; Tong D; Xiang S; Williams K; Bai W; Li GM; Bepler G; Zhang X
    J Biol Chem; 2016 May; 291(20):10783-91. PubMed ID: 26975374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.